Advertisement

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

Opening Session Panel Discussion

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Matthew Seymour, MD: A Clinical Trialist’s Perspective

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Advertisement

Advertisement

Dec

16

Today In Oncology

Phase III Trial Shows No Oncologic Benefit From Routine Preoperative MRI for Some Early Breast Cancers

Menopausal Hormone Therapy Not Associated With Increased Breast Cancer Risk

Fixed-Duration Doublet Noninferior to Continuous Ibrutinib in CLL

FDA Approves Epcoritamab for Two Follicular Lymphoma Indications

FDA Approves Regimen for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer

Advertisement

© 2025 HSP News Service, L.L.C.